Literature DB >> 15211094

New insights into the mechanisms of diabetic neuropathy.

Andrea M Vincent1, Eva L Feldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211094     DOI: 10.1023/B:REMD.0000032411.11422.e0

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  87 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia.

Authors:  A Ceriello; N Bortolotti; E Motz; C Pieri; M Marra; L Tonutti; S Lizzio; F Feletto; B Catone; C Taboga
Journal:  Metabolism       Date:  1999-12       Impact factor: 8.694

Review 3.  Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

Authors:  D Ziegler; M Reljanovic; H Mehnert; F A Gries
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

Review 4.  Botanicals and dietary supplements in diabetic peripheral neuropathy.

Authors:  Kathleen M Halat; Cathi E Dennehy
Journal:  J Am Board Fam Pract       Date:  2003 Jan-Feb

5.  Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

Authors:  R Butler; A D Morris; J J Belch; A Hill; A D Struthers
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

6.  Neurons undergo apoptosis in animal and cell culture models of diabetes.

Authors:  J W Russell; K A Sullivan; A J Windebank; D N Herrmann; E L Feldman
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

7.  High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts.

Authors:  A Solini; P Chiozzi; S Falzoni; A Morelli; R Fellin; F Di Virgilio
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

8.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus.

Authors:  M Kalousová; J Skrha; T Zima
Journal:  Physiol Res       Date:  2002       Impact factor: 1.881

10.  Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death.

Authors:  Andrea M Vincent; James A Olzmann; Michael Brownlee; W I Sivitz; James W Russell
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  28 in total

1.  Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.

Authors:  Lucy M Hinder; Claudia Figueroa-Romero; Crystal Pacut; Yu Hong; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2013-10-05       Impact factor: 8.401

2.  Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Authors:  Bhumsoo Kim; Lisa L McLean; Stephen S Philip; Eva L Feldman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

3.  Mitochondrial DNA (mtDNA) biogenesis: visualization and duel incorporation of BrdU and EdU into newly synthesized mtDNA in vitro.

Authors:  Stephen I Lentz; James L Edwards; Carey Backus; Lisa L McLean; Kristine M Haines; Eva L Feldman
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

4.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

Review 5.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

6.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Authors:  Andrea M Vincent; Koichi Kato; Lisa L McLean; Mary E Soules; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

7.  Literature-based discovery of diabetes- and ROS-related targets.

Authors:  Junguk Hur; Kelli A Sullivan; Adam D Schuyler; Yu Hong; Manjusha Pande; David J States; H V Jagadish; Eva L Feldman
Journal:  BMC Med Genomics       Date:  2010-10-27       Impact factor: 3.063

8.  Mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; John M Hayes; Timothy D Wiggin; Carey Backus; Sang Su Oh; Stephen I Lentz; Frank Brosius; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2007-07-31       Impact factor: 5.996

Review 9.  Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Authors:  Claudia Figueroa-Romero; Mahdieh Sadidi; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

10.  Vitamin E (alpha-tocopherol) supplementation in diabetic rats: effects on the proximal colon.

Authors:  Luciana P Roldi; Renata V F Pereira; Eleandro A Tronchini; Gabriela V Rizo; Célia R Scoaris; Jacqueline N Zanoni; Maria R M Natali
Journal:  BMC Gastroenterol       Date:  2009-11-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.